PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-09-26

Date Title Company
26-Sep-2022 Immunotherapy: Tollys presents new data at OTS 2022, demonstrating anti-tumor activity of TL-532  Andrew Lloyd Associates
26-Sep-2022 Immunotherapy: Tollys presents new data at OTS 2022, demonstrating anti-tumor activity of TL-532  Andrew Lloyd Associates
26-Sep-2022 Pressotherapy Systems Market Growth – CAGR of ~4.1% | Stakeholders Focus on Growth Strategies up to 2031 Wired Release
26-Sep-2022 Venlafaxine Hydrochloride Market Reach USD 1.19 billion Key Players are Pfizer, Mesha Pharma & Sun Pharmaceutical Industries Wired Release
26-Sep-2022 Skin Replacement Market Share to rise upto US$ 1,202.2 million in 2024 | Research by FMI MARKITWIRED
26-Sep-2022 Surgical Booms Market to record USD 1.43 Bn incremental growth – – North America Account for a Huge Share of 51.0% by 2022. Wired Release
26-Sep-2022 Global Hpv Testing Market Significant Growth, Various Services, Competitive Insights & Demand Analysis 2022 – 2029 Wired Release
26-Sep-2022 Orthopedic Prosthetic Devices Market Size to be US$ 2.8 Billion by till 2027 | MARKITWIRED
26-Sep-2022 SPG Microstimulator System Market Analysis and Revenue | Projected To Garner Significant Revenues By 2031 Wired Release
26-Sep-2022 Tracheal Tubes and Airway Products Market Value to be US$ 5,331 Bn in 2027 | FMI Research MARKITWIRED
26-Sep-2022 Genetically modified herpes virus delivers one-two punch against advanced cancers The Institute of Cancer Research
26-Sep-2022 Research identifies new treatment target for CNS injury and neurological disease Science Advances
26-Sep-2022 Immutep receives AUD 2.7 million research and development tax incentive from French government Immutep
26-Sep-2022 Tiziana Life Sciences Announces Purchase of Common Shares by Chief Medical Officer Tiziana Life Sciences
26-Sep-2022 TolerogenixX Publishes Three-Year Follow-Up Data from Phase I Trial of Immune Tolerance-Inducing MIC-Lx Cell Therapy TolerogeniXx GmbH
26-Sep-2022 Chiesi is recertified as a B Corp and sets new tougher objectives for action by 2025 Chiesi
26-Sep-2022 Coave Therapeutics to Present at Cell and Gene Meeting on the Mesa Coave Therapeutics
26-Sep-2022 TILT Biotherapeutics Collaborates with MSD on Immunotherapy Clinical Trial in Checkpoint Inhibitor Refractory Non-Small Cell Lung Cancer TILT Biotherapeutics
26-Sep-2022 Kupando Raises €13 Million in Series A Funding Round B3C newswire
26-Sep-2022 Electrocardiography (ECG or EKG) Market Development, Revenue, Demand and Forecast to 2031 Wired Release